Phase 3 Chronic Liver Disease Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 3
In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop
Chronic Liver Disease
Green Cross Wellbeing226 enrolled1 locationNCT06493799
Recruiting
Phase 3
The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Jiangsu HengRui Medicine Co., Ltd.101 enrolled1 locationNCT06507436
Recruiting
Phase 3
Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Hepatocellular CarcinomaAdvanced Chronic Liver DiseasePortal Hypertension
Hospital Universitari Vall d'Hebron Research Institute300 enrolled1 locationNCT06434753